A detailed history of Acropolis Investment Management, LLC transactions in Danaher Corp stock. As of the latest transaction made, Acropolis Investment Management, LLC holds 2,568 shares of DHR stock, worth $603,608. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,568
Previous 2,567 0.04%
Holding current value
$603,608
Previous $713,000 -0.0%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $239 - $280
1 Added 0.04%
2,568 $713,000
Q2 2024

Jul 16, 2024

SELL
$235.51 - $267.98 $3,768 - $4,287
-16 Reduced 0.62%
2,567 $641,000
Q1 2024

Apr 17, 2024

SELL
$224.58 - $256.19 $19,538 - $22,288
-87 Reduced 3.26%
2,583 $645,000
Q4 2023

Jan 16, 2024

BUY
$185.1 - $233.13 $2,406 - $3,030
13 Added 0.49%
2,670 $617,000
Q3 2023

Oct 11, 2023

BUY
$233.08 - $265.59 $428,167 - $487,888
1,837 Added 224.02%
2,657 $659,000
Q1 2023

Apr 11, 2023

BUY
$239.75 - $277.0 $4,795 - $5,540
20 Added 2.5%
820 $206,000
Q4 2022

Jan 11, 2023

BUY
$241.42 - $282.29 $1,931 - $2,258
8 Added 1.01%
800 $0
Q3 2022

Oct 12, 2022

SELL
$247.06 - $1507.4 $1,729 - $10,551
-7 Reduced 0.88%
792 $205,000
Q2 2022

Jul 15, 2022

BUY
$237.11 - $299.66 $7,350 - $9,289
31 Added 4.04%
799 $202,000
Q1 2022

Apr 08, 2022

SELL
$257.27 - $315.76 $12,091 - $14,840
-47 Reduced 5.77%
768 $225,000
Q3 2021

Oct 12, 2021

BUY
$272.21 - $332.43 $13,066 - $15,956
48 Added 6.26%
815 $235,000
Q2 2021

Jul 16, 2021

SELL
$225.08 - $271.69 $32,186 - $38,851
-143 Reduced 15.71%
767 $206,000
Q3 2020

Oct 09, 2020

SELL
$177.16 - $215.33 $36,494 - $44,357
-206 Reduced 18.46%
910 $196,000
Q1 2020

Apr 10, 2020

BUY
$121.39 - $169.05 $135,471 - $188,659
1,116 New
1,116 $154,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Acropolis Investment Management, LLC Portfolio

Follow Acropolis Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acropolis Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acropolis Investment Management, LLC with notifications on news.